Dermapharm Holding SE (DMP) — Cash Flow Reinvestment Rate
Dermapharm Holding SE (DMP) has a Cash Flow Reinvestment Rate of 0.13x as of December 2025, reinvesting €11.88 Million (capex €11.88 Million ) from operating cash flow of €92.40 Million. Explore DMP capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Dermapharm Holding SE across 12 annual periods. Also explore balance sheet size of Dermapharm Holding SE for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dermapharm Holding SE (2014–2025)
Year-by-year capital reinvestment analysis for Dermapharm Holding SE. For live market cap and broader valuation context, see Dermapharm Holding SE stock valuation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | €42.12 Million | €181.51 Million | €42.12 Million | ▼ -31.1% |
| 2024 | 0.34x | €67.85 Million | €201.38 Million | €38.24 Million | ▼ -83.8% |
| 2023 | 2.08x | €456.97 Million | €219.42 Million | €41.54 Million | ▲ +335.4% |
| 2022 | 0.48x | €138.02 Million | €288.53 Million | €39.01 Million | ▲ +9.4% |
| 2021 | 0.44x | €109.46 Million | €250.37 Million | €61.20 Million | ▲ +30.5% |
| 2020 | 0.34x | €43.93 Million | €131.10 Million | €40.80 Million | ▼ -68.3% |
| 2019 | 1.06x | €106.29 Million | €100.61 Million | €46.44 Million | ▲ +542.0% |
| 2018 | 0.16x | €26.18 Million | €159.13 Million | €25.97 Million | ▼ -80.9% |
| 2017 | 0.86x | €74.75 Million | €86.74 Million | €74.72 Million | ▲ +271.7% |
| 2016 | 0.23x | €17.80 Million | €76.78 Million | €17.76 Million | ▼ -54.8% |
| 2015 | 0.51x | €20.70 Million | €40.38 Million | €14.93 Million | ▼ -18.6% |
| 2014 | 0.63x | €34.19 Million | €54.26 Million | €28.42 Million | — |